SCHEMBL29530613

SCHEMBL29530613

CCC(C)N(C(=O)c1cc(-c2cn(-c3ccc(C(=O)O)c(O)c3)nn2)nc(-c2cn(-c3ccc(C(=O)O)c(O)c3)nn2)c1)C(C)CC

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NME4 O00746 1/20 0.40
▸ GCDH Q92947 1/20 0.40
▸ SIRT5 Q9NXA8 1/20 0.40
▸ MAPT P10636 1/20 0.37
▸ SNCA P37840 1/20 0.37
▸ MYC P01106 2/20 0.36
▸ KLKB1 P03952 1/20 0.36
▸ CTSB P07858 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ MIF P14174 9/20 0.35
▸ LDHA P00338 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22846285 1.00 NME4 (0.40) NME4GCDHSIRT5MAPTSNCA
SCHEMBL22846544 0.87 NME4 (0.43) NME4GCDHSIRT5MAPTSNCA
SCHEMBL29531028 0.87 NME4 (0.43) NME4GCDHSIRT5MAPTSNCA
SCHEMBL22834286 0.85 NME4 (0.41) NME4GCDHSIRT5MAPTSNCA
SCHEMBL22834008 0.85 NME4 (0.42) NME4GCDHSIRT5MAPTSNCA
SCHEMBL29531124 0.84 NME4 (0.41) NME4GCDHSIRT5MAPTSNCA
SCHEMBL22846286 0.84 NME4 (0.41) NME4GCDHSIRT5MAPTSNCA
SCHEMBL22834275 0.83 NME4 (0.40) NME4GCDHSIRT5MAPTSNCA
SCHEMBL22834173 0.82 MAPT (0.47) NME4GCDHSIRT5MAPTSNCA
SCHEMBL29450892 0.82 LDHA (0.34) MIFLDHAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3994262-A1 ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS Stratos Genomics Inc. (US) 2022-05-11 — — EP claimed
CN-119823106-A Enhanced nucleic acid polymerization by aromatic compounds 豪夫迈·罗氏有限公司 2025-04-15 — — CN disclosed
US-20250075265-A1 ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS ROCHE SEQUENCING SOLUTIONS INC (US) 2025-03-06 — — US disclosed
CN-114144520-B Enhanced nucleic acid polymerization by aromatic compounds 豪夫迈·罗氏有限公司 2024-12-13 — — CN disclosed
US-11970731-B2 Enhancement of nucleic acid polymerization by aromatic compounds Roche Sequencing Solutions, Inc. (US) 2024-04-30 — — US disclosed
EP-3994262-A1 ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS Stratos Genomics Inc. (US) 2022-05-11 — — EP disclosed
US-20220112548-A1 ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS Roche Sequencing Solutions, Inc. 2022-04-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11970731-B2 Enhancement of nucleic acid polymerization by aromatic compounds POLN, POLB, POLRMT NME4 139/4885GCDH 1933/4885SIRT5 4709/4885
US-20250075265-A1 ENHANCEMENT OF NUCLEIC ACID POLYMERIZATION BY AROMATIC COMPOUNDS POLN, POLB, POLRMT NME4 139/4885GCDH 1933/4885SIRT5 4709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback